NF2 is a candidate diagnosis, prognostic, and immunotherapeutic biomarker: a systematic pan-cancer analysis
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Neurofibromin 2 (NF2) is highly expressed in most tumors and shows potential for early cancer diagnosis and prognosis. NF2 expression is linked to the tumor immune microenvironment, suggesting its utility in predicting immunotherapy response.
Area Of Science
- Oncology
- Genetics
- Immunology
Background
- Neurofibromin 2 (NF2) regulates critical cellular processes including transcription, translation, ubiquitination, and micro-RNA biosynthesis.
- Aberrant NF2 expression is implicated in the tumorigenesis of mesothelioma, meningioma, and breast cancer.
- A comprehensive pan-cancer analysis of NF2's role in cancer diagnosis, prognosis, and immune prediction is lacking.
Purpose Of The Study
- To conduct a comprehensive pan-cancer analysis of the NF2 gene.
- To explore the association of NF2 expression with tumor diagnosis, prognosis, and immune characteristics.
- To evaluate NF2 as a potential biomarker for cancer diagnosis, prognosis, and immunotherapy.
Main Methods
- Utilized extensive data from TCGA, GTEx, CCLE, CIBERSORT, HPA, and cBioPortal.
- Employed various bioinformatics methods to analyze NF2's role across multiple cancer types.
- Investigated associations between NF2 expression, tumor diagnosis, prognosis, immune cell infiltration, TMB, MSI, and RNA modification genes.
Main Results
- NF2 was found to be highly expressed in the majority of tumors analyzed.
- NF2 demonstrated early diagnostic value in 13 tumor types and was significantly associated with prognosis in most cancers.
- NF2 expression correlated with immune cells, signaling pathways, tumor mutational burden (TMB), and microsatellite instability (MSI) in various cancers.
Conclusions
- NF2 serves as a valuable marker for early tumor diagnosis and prognosis assessment.
- NF2 expression is strongly linked to the tumor immune microenvironment.
- NF2 is a promising biomarker for predicting immunotherapy efficacy, including immune checkpoint inhibitors.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
